Lipocine Inc(LPCN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LPCN Lipocine Inc

休市中 12-05 16:00:00 EST

3.15

+0.05

+1.61%

盘后3.15

+0.000.00%

16:00 EST

最高3.31	最低3.14	成交量2.63万
今开3.14	昨收3.10	日振幅5.48%
总市值1,749万	流通市值1,699万	总股本555.19万
成交额8.43万	换手率0.49%	流通股本539.41万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"LPCN","market":"US","secType":"STK","nameCN":"Lipocine Inc","latestPrice":3.15,"timestamp":1764968400000,"preClose":3.1,"halted":0,"volume":26307,"hourTrading":{"tag":"盘后","latestPrice":3.15,"preClose":3.15,"latestTime":"16:00 EST","volume":100,"amount":315,"timestamp":1764968401948},"delay":0,"floatShares":5394100,"shares":5551931,"eps":-1.020434,"marketStatus":"休市中","change":0.05,"latestTime":"12-05 16:00:00 EST","open":3.14,"high":3.31,"low":3.14,"amount":84314.924143,"amplitude":0.054839,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.020434,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765184400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1395374400000,"exchange":"NASDAQ","adjPreClose":3.1,"preHourTrading":{"tag":"盘前","latestPrice":3.14,"preClose":3.1,"latestTime":"08:34 EST","volume":300,"amount":942,"timestamp":1764941662442},"postHourTrading":{"tag":"盘后","latestPrice":3.15,"preClose":3.15,"latestTime":"16:00 EST","volume":100,"amount":315,"timestamp":1764968401948},"volumeRatio":1.2771256317571957,"impliedVol":2.2886,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/LPCN","defaultTab":"news","newsList":[{"id":"1159082608","title":"Lipocine Inc：药物安全监测委员会会议评估三分之一计划参与者，研究将按计划继续进行","url":"https://stock-news.laohu8.com/highlight/detail?id=1159082608","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159082608?lang=zh_cn&edition=full","pubTime":"2025-11-18 21:02","pubTimestamp":1763470937,"startTime":"0","endTime":"0","summary":"Lipocine Inc：药物安全监测委员会会议评估三分之一计划参与者，研究将按计划继续进行","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LPCN"],"gpt_icon":0},{"id":"1184900780","title":"Lipocine在Lpcn 1154治疗产后抑郁症的三期试验中强调了有希望的中期安全性特征","url":"https://stock-news.laohu8.com/highlight/detail?id=1184900780","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184900780?lang=zh_cn&edition=full","pubTime":"2025-11-18 21:01","pubTimestamp":1763470880,"startTime":"0","endTime":"0","summary":"Lipocine在Lpcn 1154治疗产后抑郁症的三期试验中强调了有希望的中期安全性特征","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LPCN","BK4007"],"gpt_icon":0},{"id":"2581211720","title":"Lipocine Inc.盘中异动 股价大涨5.47%报2.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2581211720","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581211720?lang=zh_cn&edition=full","pubTime":"2025-11-06 22:47","pubTimestamp":1762440457,"startTime":"0","endTime":"0","summary":"北京时间2025年11月06日22时47分，Lipocine Inc.股票出现波动，股价急速拉升5.47%。截至发稿，该股报2.70美元/股，成交量8526股，换手率0.16%，振幅3.13%。Lipocine Inc.股票所在的生物技术行业中，整体涨幅为0.27%。Lipocine Inc.公司简介：Lipocine Inc 是一家处于临床阶段的生物制药公司，致力于利用其专有药物递送技术研发药物递送解决方案。Lipocine 既自行研发候选药物，也代表或与企业合作伙伴合作开发候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106224737a48db565&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106224737a48db565&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LPCN","BK4007"],"gpt_icon":0},{"id":"2577334974","title":"Lipocine Inc.盘中异动 急速跳水5.46%报2.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2577334974","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577334974?lang=zh_cn&edition=full","pubTime":"2025-10-23 01:11","pubTimestamp":1761153077,"startTime":"0","endTime":"0","summary":"北京时间2025年10月23日01时11分，Lipocine Inc.股票出现波动，股价快速下挫5.46%。截至发稿，该股报2.77美元/股，成交量4.0275万股，换手率0.74%，振幅5.46%。Lipocine Inc.股票所在的生物技术行业中，整体跌幅为0.55%。Lipocine Inc.公司简介：Lipocine Inc 是一家处于临床阶段的生物制药公司，致力于利用其专有药物递送技术研发药物递送解决方案。Lipocine 既自行研发候选药物，也代表或与企业合作伙伴合作开发候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251023011117973cf4a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251023011117973cf4a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LPCN","BK4007"],"gpt_icon":0},{"id":"2558886669","title":"Lipocine Inc.盘中异动 股价大涨5.80%报3.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558886669","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558886669?lang=zh_cn&edition=full","pubTime":"2025-08-11 22:02","pubTimestamp":1754920922,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日22时02分，Lipocine Inc.股票出现异动，股价急速拉升5.80%。截至发稿，该股报3.10美元/股，成交量5580股，换手率0.10%，振幅2.22%。Lipocine Inc.股票所在的生物技术行业中，整体涨幅为0.39%。Lipocine Inc.公司简介：Lipocine Inc 是一家处于临床阶段的生物制药公司，致力于利用其专有药物递送技术研发药物递送解决方案。Lipocine 既自行研发候选药物，也代表或与企业合作伙伴合作开发候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508112202029740ef7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508112202029740ef7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LPCN"],"gpt_icon":0},{"id":"2558249681","title":"Lipocine Inc.2025财年第二财季实现净利润-2.21百万美元，同比增加28.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558249681","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558249681?lang=zh_cn&edition=full","pubTime":"2025-08-11 00:01","pubTimestamp":1754841690,"startTime":"0","endTime":"0","summary":"8月11日，Lipocine Inc.公布财报，公告显示公司2025财年第二财季净利润为-2.21百万美元，同比增加28.01%；其中营业收入为622849.00美元，同比增加595.42%，每股基本收益为-0.41美元。从资产负债表来看，Lipocine Inc.总负债1.45百万美元，其中短期债务0.00美元，资产负债比为12.82，流动比率为12.71。机构评级：截至2025年8月11日，当前有2家机构对Lipocine Inc.目标价做出预测，其中目标均价为7.38美元，其中最低目标价为6.75美元，最高目标价为8.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811000342a4805778&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811000342a4805778&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LPCN"],"gpt_icon":0},{"id":"2551192393","title":"Lipocine Inc.盘中异动 急速跳水5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551192393","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551192393?lang=zh_cn&edition=full","pubTime":"2025-07-16 03:56","pubTimestamp":1752609403,"startTime":"0","endTime":"0","summary":"北京时间2025年07月16日03时56分，Lipocine Inc.股票出现波动，股价快速下跌5.31%。截至发稿，该股报3.03美元/股，成交量3.2822万股，换手率0.61%，振幅4.10%。Lipocine Inc.股票所在的生物技术行业中，整体跌幅为1.15%。Lipocine Inc.公司简介：Lipocine Inc 是一家处于临床阶段的生物制药公司，致力于利用其专有药物递送技术研发药物递送解决方案。Lipocine 既自行研发候选药物，也代表或与企业合作伙伴合作开发候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716035644a44cfc24&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716035644a44cfc24&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LPCN"],"gpt_icon":0},{"id":"2550731796","title":"Lipocine Inc.盘中异动 股价大涨5.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550731796","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550731796?lang=zh_cn&edition=full","pubTime":"2025-07-11 03:09","pubTimestamp":1752174552,"startTime":"0","endTime":"0","summary":"北京时间2025年07月11日03时09分，Lipocine Inc.股票出现异动，股价快速拉升5.40%。截至发稿，该股报3.38美元/股，成交量4.4932万股，换手率0.84%，振幅8.10%。Lipocine Inc.股票所在的生物技术行业中，整体涨幅为0.83%。Lipocine Inc.公司简介：Lipocine Inc 是一家处于临床阶段的生物制药公司，致力于利用其专有药物递送技术研发药物递送解决方案。Lipocine 既自行研发候选药物，也代表或与企业合作伙伴合作开发候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711030913953dc797&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711030913953dc797&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LPCN","BK4007"],"gpt_icon":0},{"id":"2549808558","title":"Lipocine Inc.盘中异动 急速拉升7.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549808558","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549808558?lang=zh_cn&edition=full","pubTime":"2025-07-07 21:36","pubTimestamp":1751895360,"startTime":"0","endTime":"0","summary":"北京时间2025年07月07日21时36分，Lipocine Inc.股票出现异动，股价大幅拉升7.74%。Lipocine Inc.股票所在的生物技术行业中，整体跌幅为0.59%。Lipocine Inc.公司简介：Lipocine Inc 是一家处于临床阶段的生物制药公司，致力于利用其专有药物递送技术研发药物递送解决方案。Lipocine 既自行研发候选药物，也代表或与企业合作伙伴合作开发候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707213600a43bf7d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707213600a43bf7d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LPCN","BK4007"],"gpt_icon":0},{"id":"2546730730","title":"Lipocine Inc.盘中异动 股价大涨5.88%报3.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546730730","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546730730?lang=zh_cn&edition=full","pubTime":"2025-06-27 00:08","pubTimestamp":1750954092,"startTime":"0","endTime":"0","summary":"北京时间2025年06月27日00时08分，Lipocine Inc.股票出现异动，股价大幅拉升5.88%。截至发稿，该股报3.42美元/股，成交量1.0403万股，换手率0.19%，振幅4.95%。Lipocine Inc.股票所在的生物技术行业中，整体跌幅为0.01%。Lipocine Inc.公司简介：Lipocine Inc 是一家处于临床阶段的生物制药公司，致力于利用其专有药物递送技术研发药物递送解决方案。Lipocine 既自行研发候选药物，也代表或与企业合作伙伴合作开发候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506270008129790229e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506270008129790229e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LPCN"],"gpt_icon":0},{"id":"2544993551","title":"Lipocine Inc.盘中异动 早盘股价大涨5.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544993551","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544993551?lang=zh_cn&edition=full","pubTime":"2025-06-17 21:47","pubTimestamp":1750168037,"startTime":"0","endTime":"0","summary":"北京时间2025年06月17日21时47分，Lipocine Inc.股票出现异动，股价快速上涨5.50%。截至发稿，该股报3.23美元/股，成交量2487股，换手率0.05%，振幅2.77%。Lipocine Inc.股票所在的生物技术行业中，整体跌幅为0.58%。其相关个股中，Acurx Pharmaceuticals, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Processa Pharmaceuticals, Inc.涨幅较大，Salarius Pharmaceuticals, Inc.、Processa Pharmaceuticals, Inc.、Acurx Pharmaceuticals, Inc.较为活跃，换手率分别为1624.25%、1311.19%、878.28%，振幅较大的相关个股有Processa Pharmaceuticals, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Acurx Pharmaceuticals, Inc.，振幅分别为107.73%、95.24%、86.94%。Lipocine Inc.公司简介：Lipocine Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617214718a4ae784f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617214718a4ae784f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LPCN","BK4007"],"gpt_icon":0},{"id":"2542539786","title":"Lipocine Inc.盘中异动 股价大涨9.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542539786","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542539786?lang=zh_cn&edition=full","pubTime":"2025-06-12 00:45","pubTimestamp":1749660341,"startTime":"0","endTime":"0","summary":"北京时间2025年06月12日00时45分，Lipocine Inc.股票出现异动，股价大幅上涨9.09%。截至发稿，该股报3.60美元/股，成交量2.24万股，换手率0.42%，振幅6.97%。Lipocine Inc.股票所在的生物技术行业中，整体涨幅为0.44%。其相关个股中，Kazia Therapeutics Limited、Vaxart, Inc. - Common Stock、Jupiter Neurosciences, Inc.涨幅较大，Nucana Plc、Kazia Therapeutics Limited、Windtree Therapeutics, Inc.较为活跃，换手率分别为10934.28%、3131.57%、193.63%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Psyence Biomedical Ltd C/Wts 25/01/2029、Kazia Therapeutics Limited，振幅分别为88.67%、84.50%、79.16%。Lipocine Inc.公司简介：Lipocine Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061200454195181b6e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061200454195181b6e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LPCN","BK4007"],"gpt_icon":0},{"id":"2542805673","title":"Lipocine Inc.盘中异动 股价大跌5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542805673","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542805673?lang=zh_cn&edition=full","pubTime":"2025-06-09 21:32","pubTimestamp":1749475951,"startTime":"0","endTime":"0","summary":"北京时间2025年06月09日21时32分，Lipocine Inc.股票出现波动，股价急速下挫5.31%。截至发稿，该股报3.00美元/股，成交量46.996万股，换手率8.78%，振幅5.50%。Lipocine Inc.股票所在的生物技术行业中，整体涨幅为0.55%。其相关个股中，Klotho Neurosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Pmgc Holdings Inc.、Klotho Neurosciences, Inc.、Synaptogenix, Inc.较为活跃，换手率分别为992.93%、898.72%、619.12%，振幅较大的相关个股有Metsera, Inc.、Tenaya Therapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.，振幅分别为128.01%、112.02%、110.76%。Lipocine Inc.公司简介：Lipocine Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506092132319514d43c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506092132319514d43c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LPCN","BK4007"],"gpt_icon":0},{"id":"2540640010","title":"Lipocine Inc.盘中异动 早盘大幅上涨5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2540640010","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540640010?lang=zh_cn&edition=full","pubTime":"2025-06-04 22:31","pubTimestamp":1749047515,"startTime":"0","endTime":"0","summary":"北京时间2025年06月04日22时31分，Lipocine Inc.股票出现波动，股价大幅上涨5.31%。截至发稿，该股报3.37美元/股，成交量3652股，换手率0.07%，振幅5.63%。Lipocine Inc.股票所在的生物技术行业中，整体涨幅为0.84%。其相关个股中，Cellectar Biosciences, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Nutriband Inc C/Wts 涨幅较大，Nucana Plc、Cellectar Biosciences, Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为1075.44%、794.78%、565.48%，振幅较大的相关个股有Cellectar Biosciences, Inc.、知临集团、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为106.81%、23.19%、22.96%。Lipocine Inc.公司简介：Lipocine Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025060422315597719cc5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025060422315597719cc5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LPCN"],"gpt_icon":0},{"id":"2540179590","title":"Lipocine Inc.盘中异动 大幅上涨6.21%报3.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540179590","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540179590?lang=zh_cn&edition=full","pubTime":"2025-06-02 21:40","pubTimestamp":1748871620,"startTime":"0","endTime":"0","summary":"北京时间2025年06月02日21时40分，Lipocine Inc.股票出现波动，股价大幅拉升6.21%。截至发稿，该股报3.59美元/股，成交量4267股，换手率0.08%，振幅0.00%。Lipocine Inc.股票所在的生物技术行业中，整体涨幅为0.87%。其相关个股中，Oragenics Inc.、Nutriband Inc C/Wts 、Vera Therapeutics, Inc.涨幅较大，Oragenics Inc.、Plus Therapeutics, Inc.、Nucana Plc较为活跃，换手率分别为690.87%、270.05%、182.34%，振幅较大的相关个股有Oragenics Inc.、Nutriband Inc C/Wts 、Immatics N V C/Wts 01/07/2025 ，振幅分别为61.58%、41.96%、38.04%。Lipocine Inc.公司简介：Lipocine Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602214020a496be31&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602214020a496be31&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LPCN"],"gpt_icon":0},{"id":"2539278762","title":"Lipocine Inc.盘中异动 早盘股价大涨5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2539278762","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539278762?lang=zh_cn&edition=full","pubTime":"2025-05-30 22:02","pubTimestamp":1748613768,"startTime":"0","endTime":"0","summary":"北京时间2025年05月30日22时02分，Lipocine Inc.股票出现波动，股价快速拉升5.53%。截至发稿，该股报3.53美元/股，成交量3596股，换手率0.07%，振幅1.05%。Lipocine Inc.股票所在的生物技术行业中，整体跌幅为4.33%。Lipocine Inc.公司简介：Lipocine Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530220248a492f777&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530220248a492f777&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LPCN","BK4007"],"gpt_icon":0},{"id":"2539261655","title":"HC Wainwright & Co.：假定Lipocine(LPCN.US)买入评级, 目标价8.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2539261655","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539261655?lang=zh_cn&edition=full","pubTime":"2025-05-29 22:51","pubTimestamp":1748530282,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：假定Lipocine(LPCN.US)买入评级, 目标价8.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/29225150751995.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LPCN"],"gpt_icon":0},{"id":"2538498686","title":"Lipocine Inc.盘中异动 大幅上涨5.87%报3.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2538498686","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538498686?lang=zh_cn&edition=full","pubTime":"2025-05-27 23:13","pubTimestamp":1748358823,"startTime":"0","endTime":"0","summary":"北京时间2025年05月27日23时13分，Lipocine Inc.股票出现异动，股价急速上涨5.87%。截至发稿，该股报3.79美元/股，成交量1.578万股，换手率0.29%，振幅7.27%。Lipocine Inc.股票所在的生物技术行业中，整体涨幅为1.09%。其相关个股中，Forte Biosciences, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Aeon Biopharma, Inc.涨幅较大，Nucana Plc、Aeon Biopharma, Inc.、Imunon, Inc.较为活跃，换手率分别为449.29%、240.47%、119.99%，振幅较大的相关个股有Revolution Medicines Inc C/Wts 17/12/2026 、Apollomics Inc C/Wts 01/04/2028 、Protagenic Therapeutics Inc C/Wts 26/04/2026 ，振幅分别为69.88%、61.32%、60.00%。Lipocine Inc.公司简介：Lipocine Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052723134395047a7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052723134395047a7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LPCN","BK4007"],"gpt_icon":0},{"id":"2518207789","title":"Lipocine Inc.盘中异动 下午盘股价大跌5.19%报3.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518207789","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518207789?lang=zh_cn&edition=full","pubTime":"2025-03-11 02:10","pubTimestamp":1741630236,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日02时10分，Lipocine Inc.股票出现波动，股价急速跳水5.19%。截至发稿，该股报3.26美元/股，成交量7167股，换手率0.13%，振幅4.36%。Lipocine Inc.股票所在的生物技术行业中，整体涨幅为0.69%。其相关个股中，Aeon Biopharma, Inc.、Mineralys Therapeutics, Inc.、Checkpoint Therapeutics, Inc.涨幅较大，Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.较为活跃，换手率分别为5737.61%、3831.85%、995.55%，振幅较大的相关个股有Aeon Biopharma, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Biodexa Pharmaceuticals Plc，振幅分别为90.44%、88.14%、58.34%。Lipocine Inc.公司简介：Lipocine Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031102103698a2d3d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031102103698a2d3d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LPCN"],"gpt_icon":0},{"id":"2517651941","title":"Lipocine Inc.盘中异动 股价大涨5.86%报3.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517651941","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517651941?lang=zh_cn&edition=full","pubTime":"2025-03-06 00:28","pubTimestamp":1741192105,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日00时28分，Lipocine Inc.股票出现异动，股价急速上涨5.86%。截至发稿，该股报3.25美元/股，成交量3538股，换手率0.07%，振幅6.51%。Lipocine Inc.股票所在的生物技术行业中，整体涨幅为1.11%。其相关个股中，Chimerix, Inc.、Nutriband Inc C/Wts 、Radiopharm Theranostics Limited涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为907.09%、294.35%、279.53%，振幅较大的相关个股有Nkgen Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为82.59%、54.27%、41.26%。Lipocine Inc.公司简介：Lipocine Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306002826abe9d484&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306002826abe9d484&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LPCN"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.lipocine.com","stockEarnings":[{"period":"1week","weight":-0.0843},{"period":"1month","weight":0.2305},{"period":"3month","weight":0.09},{"period":"6month","weight":-0.0063},{"period":"1year","weight":-0.3687},{"period":"ytd","weight":-0.3545}],"compareEarnings":[{"period":"1week","weight":0.0034},{"period":"1month","weight":0.012},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1445},{"period":"1year","weight":0.1303},{"period":"ytd","weight":0.17}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Lipocine Inc.在1997年6月19日注册于特拉华州，公司是一家专业化生物制药公司，致力于其口服给药技术在生物制药领域的应用和发展。Lipocine公司的专有给药技术通过口服治疗方案以提高患者的依从性和安全性。公司的主要开发项目面向吸收效果差的口服药解决方案，这一类药吸收效果较差，剂量不足以使药效发挥到循环系统。公司有一系列专利候选产品，具有以下特点：具有良好的药代动力学特性、有利于满足低剂量要求、绕过初步的代谢过程、减少副作用、消除了限制药物活性的胃肠道相互作用。公司的候选产品LPCN1021是一个第三准备阶段的口服睾酮替代治疗药（TRT），剂量为一天使用两次，十分方便。","yearOnYearQuotes":[{"month":1,"riseRate":0.636364,"avgChangeRate":0.0413},{"month":2,"riseRate":0.636364,"avgChangeRate":0.072883},{"month":3,"riseRate":0.454545,"avgChangeRate":0.019225},{"month":4,"riseRate":0.416667,"avgChangeRate":-0.05842},{"month":5,"riseRate":0.416667,"avgChangeRate":0.023149},{"month":6,"riseRate":0.666667,"avgChangeRate":0.059734},{"month":7,"riseRate":0.583333,"avgChangeRate":0.061431},{"month":8,"riseRate":0.333333,"avgChangeRate":0.008739},{"month":9,"riseRate":0.25,"avgChangeRate":-0.065749},{"month":10,"riseRate":0.25,"avgChangeRate":-0.080769},{"month":11,"riseRate":0.666667,"avgChangeRate":0.007974},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.031587}],"exchange":"NASDAQ","name":"Lipocine Inc","nameEN":"Lipocine"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Lipocine Inc(LPCN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Lipocine Inc(LPCN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Lipocine Inc,LPCN,Lipocine Inc股票,Lipocine Inc股票老虎,Lipocine Inc股票老虎国际,Lipocine Inc行情,Lipocine Inc股票行情,Lipocine Inc股价,Lipocine Inc股市,Lipocine Inc股票价格,Lipocine Inc股票交易,Lipocine Inc股票购买,Lipocine Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Lipocine Inc(LPCN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Lipocine Inc(LPCN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}